Matt Krebs
mattokrebs.bsky.social
BioCentury Inc. ( www.biocentury.com ) * Empowering Biopharma & Finance Execs | Travel Junkie & weekend warrior golfer * Global Strategic Account Manager & Growth Team Sales Manager
👤 Joined on 08 March 2025
279
Followers
575
Following
56
Total Posts
📜 Kullanıcı Geçmişi
- 08 Mar 2025, 01:49
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@mattokrebs.bsky.social
❤️ Beğendiği Gönderiler
My BioCentury colleague Lauren Martz looks ahead to a big year of catalysts, with innovations in RNA-targeting therapies leading the way. www.biocentury.com/article/6581...
Show PostFDA's CBER will review Moderna's mRNA-1010 flu vaccine after all.... www.accessnewswire.com/newsroom/en/...
Show PostI spoke with co-founder Krishna Polu about the launch of R1 Therapeutics. The start-up has obtained most global rights to a therapy from China-based Alebund that inhibits phosphate transporters in the intestine to treat a common complication of kidney disease: www.biocentury.com/article/6587...
Show Post